MiNK Therapeutics, Inc. (INKT) Financials

INKT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 9.6 billion ?
March 31, 2026 10.4 million 23.1 million
Dec. 31, 2025 14.2 million 28.5 million
Sept. 30, 2025 15.0 million 28.5 million

INKT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -2.1 billion 422.2 million
March 31, 2026 -1.7 million 630386
Dec. 31, 2025 -2.1 million 2.7 billion
Sept. 30, 2025 -941350 620585

INKT Net Income

No data available :(

INKT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 8.8 billion - -
March 31, 2026 9.5 million - -
Dec. 31, 2025 13.4 million - -
Sept. 30, 2025 14.3 million - -

INKT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 ?
March 31, 2026 4.8 million
Dec. 31, 2025 4.3 million
Sept. 30, 2025 4.4 million

INKT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 1.9 million 1.3 million -
March 31, 2026 - 1.2 billion 1.7 billion -
Dec. 31, 2025 3 5.8 billion 6.7 billion -
Sept. 30, 2025 2 1.1 million 1.8 million -

INKT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 36066
Dec. 31, 2025 - 38563
Sept. 30, 2025 - 43654

INKT

Price: $12

52 week price:
8.48
18.17

Earnings Per Share: -2.80 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 4128

Market Capitalization: 57.5 million

Links: